Skip to main content
Erschienen in:

02.01.2020 | Original Article

Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome

Coincidence or Relevant?

verfasst von: Patrick Kruczek, Barbara Bellenberg, Theodor Lutz, Ruth Schneider, Christian Ahlborn, Ralf Gold, Odo Köster, Carsten Lukas

Erschienen in: Clinical Neuroradiology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Developmental venous anomalies (DVA) are congenital malformations of veins that drain brain parenchyma, with a prevalence up to 9.3% in normal populations and 29.5% in multiple sclerosis (MS) patients. Study purpose was to determine prevalence of DVAs in patients with clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS) and to assess whether DVAs are related to altered clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) laboratory parameters.

Methods

Routine neurological and MRI examinations took place in a single center in 93 patients (39 CIS, 54 RRMS). Clinical disability (n = 93), MRI (n ≤ 90), CSF (n ≤ 82) parameters and DVA status were determined and compared statistically.

Results

A total of 29 DVAs were detected in 25 patients (25/93; 26.9%), 10 in 39 CIS patients and 15 in 54 RRMS patients. Most parameters were not significantly altered in patients with DVAs; no associated higher conversion rates from CIS to MS at 1–year (p = 0.411) or 2‑year follow-up (p = 0.281) were registered.

Conclusion

A higher prevalence of DVAs was detected in CIS and early MS patients than reported in non-MS populations, congruent to recent literature. The DVAs were not associated with significantly altered clinical outcomes, brain atrophy rates or disease progression, and no associated higher risk of CIS patients for converting to MS was found.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Lasjaunias P, Burrows P, Planet C. Developmental venous anomalies (DVA): the so-called venous angioma. Neurosurg Rev. 1986;9:233–42.CrossRef Lasjaunias P, Burrows P, Planet C. Developmental venous anomalies (DVA): the so-called venous angioma. Neurosurg Rev. 1986;9:233–42.CrossRef
2.
Zurück zum Zitat Truwit CL. Venous angioma of the brain: history, significance, and imaging findings. AJR Am J Roentgenol. 1992;159:1299–307.CrossRefPubMed Truwit CL. Venous angioma of the brain: history, significance, and imaging findings. AJR Am J Roentgenol. 1992;159:1299–307.CrossRefPubMed
3.
Zurück zum Zitat Cabanes J, Blasco R, García M, Tamarit L. Cerebral venous angiomas. Surg Neurol. 1979;11:385–9.PubMed Cabanes J, Blasco R, García M, Tamarit L. Cerebral venous angiomas. Surg Neurol. 1979;11:385–9.PubMed
4.
Zurück zum Zitat Sarwar M, McCormick WF. Intracerebral venous angioma. Case report and review. Arch Neurol. 1978;35:323–5.CrossRef Sarwar M, McCormick WF. Intracerebral venous angioma. Case report and review. Arch Neurol. 1978;35:323–5.CrossRef
5.
Zurück zum Zitat Lee C, Pennington MA, Kenney CM 3rd. MR evaluation of developmental venous anomalies: medullary venous anatomy of venous angiomas. AJNR Am J Neuroradiol. 1996;17:61–70.PubMed Lee C, Pennington MA, Kenney CM 3rd. MR evaluation of developmental venous anomalies: medullary venous anatomy of venous angiomas. AJNR Am J Neuroradiol. 1996;17:61–70.PubMed
6.
Zurück zum Zitat Gökçe E, Acu B, Beyhan M, Celikyay F, Celikyay R. Magnetic resonance imaging findings of developmental venous anomalies. Clin Neuroradiol. 2014;24:135–43.CrossRefPubMed Gökçe E, Acu B, Beyhan M, Celikyay F, Celikyay R. Magnetic resonance imaging findings of developmental venous anomalies. Clin Neuroradiol. 2014;24:135–43.CrossRefPubMed
7.
Zurück zum Zitat Cho SB, Choi DS, Ryu HG, Shin HS, Kim JE, Choi HY, Park MJ,.Choi HC, Son S. Susceptibility-weighted MR imaging for the detection of developmental venous anomaly: comparison with T2 and FLAIR imaging. J Korean Soc Magn Reson Med. 2014;18:200–7.CrossRef Cho SB, Choi DS, Ryu HG, Shin HS, Kim JE, Choi HY, Park MJ,.Choi HC, Son S. Susceptibility-weighted MR imaging for the detection of developmental venous anomaly: comparison with T2 and FLAIR imaging. J Korean Soc Magn Reson Med. 2014;18:200–7.CrossRef
8.
Zurück zum Zitat Brinjikji W, El-Rida El-Masri A, Wald JT, Lanzino G. Prevalence of developmental venous anomalies increases with age. Stroke. 2017;48:1997–9.CrossRef Brinjikji W, El-Rida El-Masri A, Wald JT, Lanzino G. Prevalence of developmental venous anomalies increases with age. Stroke. 2017;48:1997–9.CrossRef
9.
Zurück zum Zitat Halicioglu S, Turkoglu SA. Role of developmental venous anomalies in etiopathogenesis of demyelinating diseases. Int J Neurosci. 2019;129:245–51.CrossRef Halicioglu S, Turkoglu SA. Role of developmental venous anomalies in etiopathogenesis of demyelinating diseases. Int J Neurosci. 2019;129:245–51.CrossRef
10.
Zurück zum Zitat Sasani MR, Dehghan AR, Ali Reza N. The relationship of multiple sclerosis and cerebral developmental venous anomaly with an advantageous role in the multiple sclerosis diagnosis. Iran J Neurol. 2017;16:168–72.PubMedPubMedCentral Sasani MR, Dehghan AR, Ali Reza N. The relationship of multiple sclerosis and cerebral developmental venous anomaly with an advantageous role in the multiple sclerosis diagnosis. Iran J Neurol. 2017;16:168–72.PubMedPubMedCentral
11.
Zurück zum Zitat Courville CB. Morphology of small vascular malformations of the brain. With particular reference to the mechanism of their drainage. J Neuropathol Exp Neurol. 1963;22:274–84.CrossRef Courville CB. Morphology of small vascular malformations of the brain. With particular reference to the mechanism of their drainage. J Neuropathol Exp Neurol. 1963;22:274–84.CrossRef
12.
Zurück zum Zitat Wessely P, Zeiler K, Holzner F, Kristoferitsch W. Rare pathomorphologic findings in complicated migraine. Wien Klin Wochenschr. 1986;98:373–9.PubMed Wessely P, Zeiler K, Holzner F, Kristoferitsch W. Rare pathomorphologic findings in complicated migraine. Wien Klin Wochenschr. 1986;98:373–9.PubMed
13.
Zurück zum Zitat Malinvaud D, Lecanu JB, Halimi P, Avan P, Bonfils P. Tinnitus and cerebellar developmental venous anomaly. Arch Otolaryngol Head Neck Surg. 2006;132:550–3.CrossRefPubMed Malinvaud D, Lecanu JB, Halimi P, Avan P, Bonfils P. Tinnitus and cerebellar developmental venous anomaly. Arch Otolaryngol Head Neck Surg. 2006;132:550–3.CrossRefPubMed
14.
Zurück zum Zitat Pereira VM, Geibprasert S, Krings T, Aurboonyawat T, Ozanne A, Toulgoat F, Pongpech S, Lasjaunias PL. Pathomechanisms of symptomatic developmental venous anomalies. Stroke. 2008;39:3201–15.CrossRefPubMed Pereira VM, Geibprasert S, Krings T, Aurboonyawat T, Ozanne A, Toulgoat F, Pongpech S, Lasjaunias PL. Pathomechanisms of symptomatic developmental venous anomalies. Stroke. 2008;39:3201–15.CrossRefPubMed
15.
Zurück zum Zitat Burke L, Berenberg RA, Kim KS. Choreoballismus: a nonhemorrhagic complication of venous angiomas. Surg Neurol. 1984;21:245–8.CrossRef Burke L, Berenberg RA, Kim KS. Choreoballismus: a nonhemorrhagic complication of venous angiomas. Surg Neurol. 1984;21:245–8.CrossRef
16.
17.
Zurück zum Zitat Ostertun B, Solymosi L. Magnetic resonance angiography of cerebral developmental venous anomalies: its role in differential diagnosis. Neuroradiology. 1993;35:97–104.CrossRef Ostertun B, Solymosi L. Magnetic resonance angiography of cerebral developmental venous anomalies: its role in differential diagnosis. Neuroradiology. 1993;35:97–104.CrossRef
18.
Zurück zum Zitat Putnam T. The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med. 1933;209:786–90.CrossRef Putnam T. The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med. 1933;209:786–90.CrossRef
19.
Zurück zum Zitat Zivadinov R, Alexander SJ, Minagar A. Vascular pathology of multiple sclerosis. Neurol Res. 2012;34:735–7.CrossRefPubMed Zivadinov R, Alexander SJ, Minagar A. Vascular pathology of multiple sclerosis. Neurol Res. 2012;34:735–7.CrossRefPubMed
20.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.CrossRefPubMedPubMedCentral Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.CrossRef Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52.CrossRef
22.
Zurück zum Zitat Rovaris M, Comi G, Rocca MA, Cercignani M, Colombo B, Santuccio G, Filippi M. Relevance of hypointense lesions on fast fluid-attenuated inversion recovery MR images as a marker of disease severity in cases of multiple sclerosis. AJNR Am J Neuroradiol. 1999;20:813–20.PubMedPubMedCentral Rovaris M, Comi G, Rocca MA, Cercignani M, Colombo B, Santuccio G, Filippi M. Relevance of hypointense lesions on fast fluid-attenuated inversion recovery MR images as a marker of disease severity in cases of multiple sclerosis. AJNR Am J Neuroradiol. 1999;20:813–20.PubMedPubMedCentral
23.
Zurück zum Zitat Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van Hecke W, De Mey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage Clin. 2015;8:367–75.CrossRefPubMedPubMedCentral Jain S, Sima DM, Ribbens A, Cambron M, Maertens A, Van Hecke W, De Mey J, Barkhof F, Steenwijk MD, Daams M, Maes F, Van Huffel S, Vrenken H, Smeets D. Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images. Neuroimage Clin. 2015;8:367–75.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Hahn HK, Millar WS, Klinghammer O, Durkin MS, Tulipano PK, Peitgen HO. A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroimaging. Methods Inf Med. 2004;43:376–82.CrossRef Hahn HK, Millar WS, Klinghammer O, Durkin MS, Tulipano PK, Peitgen HO. A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroimaging. Methods Inf Med. 2004;43:376–82.CrossRef
25.
Zurück zum Zitat Lukas C, Hahn HK, Bellenberg B, Rexilius J, Schmid G, Schimrigk SK, Przuntek H, Köster O, Peitgen HO. Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis. Neuroradiology. 2004;46:906–15.CrossRef Lukas C, Hahn HK, Bellenberg B, Rexilius J, Schmid G, Schimrigk SK, Przuntek H, Köster O, Peitgen HO. Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis. Neuroradiology. 2004;46:906–15.CrossRef
26.
Zurück zum Zitat Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol. 2009;44:491–4.CrossRefPubMed Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol. 2009;44:491–4.CrossRefPubMed
27.
Zurück zum Zitat Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016;12:714–22.CrossRef Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016;12:714–22.CrossRef
28.
Zurück zum Zitat Dal-Bianco A, Hametner S, Grabner G, Schernthaner M, Kronnerwetter C, Reitner A, Vass C, Kircher K, Auff E, Leutmezer F, Vass K, Trattnig S. Veins in plaques of multiple sclerosis patients—a longitudinal magnetic resonance imaging study at 7 Tesla. Eur Radiol. 2015;25:2913–20.CrossRefPubMed Dal-Bianco A, Hametner S, Grabner G, Schernthaner M, Kronnerwetter C, Reitner A, Vass C, Kircher K, Auff E, Leutmezer F, Vass K, Trattnig S. Veins in plaques of multiple sclerosis patients—a longitudinal magnetic resonance imaging study at 7 Tesla. Eur Radiol. 2015;25:2913–20.CrossRefPubMed
29.
Zurück zum Zitat Rogers DM, Peckham ME, Shah LM, Wiggins RH 3rd. Association of developmental venous anomalies with demyelinating lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2018;39:97–101.CrossRefPubMedPubMedCentral Rogers DM, Peckham ME, Shah LM, Wiggins RH 3rd. Association of developmental venous anomalies with demyelinating lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2018;39:97–101.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Scotti LN, Goldman RL, Rao GR, Heinz ER. Cerebral venous angioma. Neuroradiology. 1975;9:125–8.CrossRef Scotti LN, Goldman RL, Rao GR, Heinz ER. Cerebral venous angioma. Neuroradiology. 1975;9:125–8.CrossRef
31.
Zurück zum Zitat Gaitán MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, Massacesi L, Reich DS. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol. 2011;70:22–9.CrossRefPubMedPubMedCentral Gaitán MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, Massacesi L, Reich DS. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol. 2011;70:22–9.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Kiliç T, Pamir MN, Küllü S, Eren F, Ozek MM, Black PM. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery. 2000;46:1179–91. discussion 91–2.CrossRef Kiliç T, Pamir MN, Küllü S, Eren F, Ozek MM, Black PM. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery. 2000;46:1179–91. discussion 91–2.CrossRef
33.
Zurück zum Zitat Ruiz DS, Yilmaz H, Gailloud P. Cerebral developmental venous anomalies: current concepts. Ann Neurol. 2009;66:271–83.CrossRefPubMed Ruiz DS, Yilmaz H, Gailloud P. Cerebral developmental venous anomalies: current concepts. Ann Neurol. 2009;66:271–83.CrossRefPubMed
34.
Zurück zum Zitat San Millán Ruíz D, Delavelle J, Yilmaz H, Gailloud P, Piovan E, Bertramello A, Pizzini F, Rüfenacht DA. Parenchymal abnormalities associated with developmental venous anomalies. Neuroradiology. 2007;49:987–95.CrossRef San Millán Ruíz D, Delavelle J, Yilmaz H, Gailloud P, Piovan E, Bertramello A, Pizzini F, Rüfenacht DA. Parenchymal abnormalities associated with developmental venous anomalies. Neuroradiology. 2007;49:987–95.CrossRef
35.
Zurück zum Zitat Rogers DM, Shah LM, Wiggins RH 3rd. The central vein: FLAIR signal abnormalities associated with developmental venous anomalies in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2018;39:2007–13.CrossRef Rogers DM, Shah LM, Wiggins RH 3rd. The central vein: FLAIR signal abnormalities associated with developmental venous anomalies in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2018;39:2007–13.CrossRef
36.
Zurück zum Zitat Jung HN, Kim ST, Cha J, Kim HJ, Byun HS, Jeon P, Kim KH, Kim BJ, Kim HJ. Diffusion and perfusion MRI findings of the signal-intensity abnormalities of brain associated with developmental venous anomaly. AJNR Am J Neuroradiol. 2014;35:1539–42.CrossRefPubMed Jung HN, Kim ST, Cha J, Kim HJ, Byun HS, Jeon P, Kim KH, Kim BJ, Kim HJ. Diffusion and perfusion MRI findings of the signal-intensity abnormalities of brain associated with developmental venous anomaly. AJNR Am J Neuroradiol. 2014;35:1539–42.CrossRefPubMed
37.
Zurück zum Zitat Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1988;51:260–5.CrossRef Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1988;51:260–5.CrossRef
Metadaten
Titel
Developmental Venous Anomalies are More Common in Patients with Multiple Sclerosis and Clinically Isolated Syndrome
Coincidence or Relevant?
verfasst von
Patrick Kruczek
Barbara Bellenberg
Theodor Lutz
Ruth Schneider
Christian Ahlborn
Ralf Gold
Odo Köster
Carsten Lukas
Publikationsdatum
02.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 1/2021
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-019-00869-y

Neu im Fachgebiet Radiologie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Abdominale CT bei Kindern: 40% mit Zufallsbefunden

Wird bei Kindern mit stumpfem Trauma eine CT des Bauchraums veranlasst, sind in rund 40% der Fälle Auffälligkeiten zu sehen, die nichts mit dem Trauma zu tun haben. Die allerwenigsten davon sind klinisch relevant.

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den radiologischen Arbeitsaufwand. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.